1-BOC-5-碘吲哚 | 374818-66-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 1-BOC-5-碘吲哚
• 英文名称: tert-butyl 5-iodo-1H-indole-1-carboxylate
• 英文别名: N-Boc-5-iodoindole；1-Boc-5-iodoindole；tert-butyl 5-iodoindole-1-carboxylate
• CAS: 374818-66-3
• 化学式: C₁₃H₁₄INO₂
• mdl: MFCD09258644
• 分子量: 343.164
• InChiKey: RMYVMKHVFXTKPF-UHFFFAOYSA-N

物化性质

• 沸点：
  388.4±34.0 °C(Predicted)
• 密度：
  1.56±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.307
• 拓扑面积：
  31.2
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2933990090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-BOC-5-iodoindole
Synonyms: tert-Butyl 5-iodo-1H-indole-1-carboxylate

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-BOC-5-iodoindole
CAS number: 374818-66-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C13H14INO2
Molecular weight: 343.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-BOC-5-碘吲哚 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodide 、 potassium carbonate 、 三乙胺 作用下， 以 甲醇 为溶剂， 反应 22.0h， 生成 5-乙炔-1H-吲哚
  参考文献：
  名称：

  One-pot access to l-5,6-dihalotryptophans and l-alknyltryptophans using tryptophan synthase

  摘要：

  We report, for the first time, the use of tryptophan synthase in the generation of L-dihalotryptophans and L-alkynyltryptophans. These previously unpublished compounds will be useful tools in the generation of probes for chemical biology, in biosynthetic diversification and as convenient building blocks for synthesis. (C) 2016 Published by Elsevier Ltd.

  DOI：

  10.1016/j.tet.2016.02.016
• 作为产物：
  描述：

  5-碘吲哚 、 二碳酸二叔丁酯 在 四丁基硫酸氢铵 、 sodium hydroxide 作用下， 以 二氯甲烷 为溶剂， 以99%的产率得到1-BOC-5-碘吲哚
  参考文献：
  名称：

  钯催化的脱芳烃 [4 + 2]-环加成氢咔唑

  摘要：

  开发了一种通过高度非对映选择性钯催化的 [4 + 2]-环加成/脱芳构化 3-硝基吲哚来构建具有三个连续空间位阻立构中心（两个四元和一个三元）的氢咔唑的有效方法。3-硝基吲哚的环加成发生在环境条件下，1,4-两性离子中间体由 γ-亚甲基-δ-戊内酯原位生成。该方法的进一步综合效用通过产品可能的多方面转换得到证明。还探索了这种转化的催化不对称方面。

  DOI：

  10.1021/acs.joc.2c01869

文献信息

• Palladium Catalyzed Carbonylative Heck Reaction Affording Monoprotected 1,3-Ketoaldehydes
  作者：Thomas M. Gøgsig、Dennis U. Nielsen、Anders T. Lindhardt、Troels Skrydstrup

  DOI：10.1021/ol300837d

  日期：2012.5.18

  The direct carbonylative palladium catalyzed synthesis of monoprotected 1,3-ketoaldehydes is reported starting from aryl iodides applying near stoichiometric amounts of carbon monoxide. Besides representing platforms for a variety of heterocyclic structures, these motives serve as viable precursors for the highly relevant aryl methyl ketones. The presented strategy can also be adapted for the facile

  据报道，从芳基碘化物开始以接近化学计算量的一氧化碳开始，直接羰基钯催化的单保护的1，3-酮醛的羰基钯催化合成。这些动机除了代表各种杂环结构的平台外，还用作高度相关的芳基甲基酮的可行前体。所提出的策略也可以适用于13 C标记的一氧化碳的简便有效结合。
• Water-Sculpting of a Heterogeneous Nanoparticle Precatalyst for Mizoroki–Heck Couplings under Aqueous Micellar Catalysis Conditions
  作者：Haobo Pang、Yuting Hu、Julie Yu、Fabrice Gallou、Bruce H. Lipshutz

  DOI：10.1021/jacs.0c11484

  日期：2021.3.10

  Powdery, spherical nanoparticles (NPs) containing ppm levels of palladium ligated by t-Bu3P, derived from FeCl3, upon simple exposure to water undergo a remarkable alteration in their morphology leading to nanorods that catalyze Mizoroki–Heck (MH) couplings. Such NP alteration is general, shown to occur with three unrelated phosphine ligand-containing NPs. Each catalyst has been studied using X-ray

  粉末状球形纳米粒子 (NPs) 含有 ppm 级的钯，由来自 FeCl 3的t- Bu 3 P连接，在简单暴露于水中后，其形态发生显着变化，导致纳米棒催化 Mizoroki-Heck (MH) 偶联。这种 NP 改变是普遍的，显示发生在三个不相关的含膦配体的 NP 中。已使用 X 射线光电子能谱 (XPS)、能量色散 X 射线能谱 (EDX)、透射电子显微镜 (TEM) 和低温透射电子显微镜 (cryo-TEM) 分析研究了每种催化剂。专门依赖于含有t- Bu 3 的NPs 的联轴器P-连接的 Pd 在室温至 45 °C 之间的水性胶束催化条件下发生，并显示出广泛的底物范围。与这项新技术相关的其他关键特性包括产品中残留的 Pd 低、水性反应介质的循环利用以及相关的低 E 因子。galipinine 是汉考克生物碱家族的一员，其前体的合成暗示了潜在的工业应用。
• JAK INHIBITOR
  申请人：Kyowa Hakko Kirin Co., Ltd.

  公开号：EP2108642A1

  公开（公告）日：2009-10-14

  A JAK inhibitor comprising, as an active ingredient, a nitrogen-containing heterocyclic compound represented by formula (I) wherein W represents a nitrogen atom or -CH-; X represents -C (=O) - or -CHR4- (wherein R4 represents a hydrogen atom, or the like); R1 represents the formula described below [wherein Q1 represents-CR8-(wherein R8 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); Q2 represents -NR15- (wherein R15 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); and R5 and R6 may be the same or different and each represents a hydrogen atom, halogen, carboxy, substituted or unsubstituted lower alkyl, or the like], or the like; and R2 and R3 may be the same or different and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, or the like} or a pharmaceutically acceptable salt thereof.

  一种JAK抑制剂，其作为活性成分的是由式(I)表示的含氮杂环化合物 其中W代表氮原子或-CH-; X代表-C(=O)-或-CHR4-(其中R4代表氢原子或类似物); R1代表下述式[其中Q1代表-CR8-(其中R8代表氢原子、取代或未取代的较低烷基或类似物); Q2代表-NR15-(其中R15代表氢原子、取代或未取代的较低烷基或类似物);而R5和R6可以相同也可以不同，每个代表氢原子、卤素、羧基、取代或未取代的较低烷基或类似物，或类似物;而 R2和R3可以相同也可以不同，每个代表氢原子、卤素、取代或未取代的较低烷基或类似物}或其药学上可接受的盐。
• Palladium-catalysed aminosulfonylation of aryl-, alkenyl- and heteroaryl halides: scope of the three-component synthesis of N-aminosulfonamides
  作者：Edward J. Emmett、Charlotte S. Richards-Taylor、Bao Nguyen、Alfonso Garcia-Rubia、Barry R. Hayter、Michael C. Willis

  DOI：10.1039/c2ob07034k

  日期：——

  By using DABCO·(SO2)2, DABSO, as a solid bench-stable SO2-equivalent, the palladium-catalysed aminosulfonylation of aryl-, alkenyl- and heteroaryl halides has been achieved. N,N-Dialkylhydrazines are employed as the N-nucleophiles and provide N-aminosulfonamides as the products in good to excellent yields. The reactions are operationally simple to perform, requiring only a slight excess of SO2 (1.2–2.2 equiv.), and tolerate a variety of substituents on the halide coupling partner. Variation of the hydrazine component is also demonstrated. The use of N,N-dibenzylhydrazine as the N-nucleophile delivers N-aminosulfonamide products that can be converted into the corresponding primary sulfonamides using a high-yielding, telescoped, deprotection sequence. The ability to employ hydrazine·SO2 complexes as both the N-nucleophile and SO2 source is also illustrated.

  通过使用DABCO·(SO2)2，即DABSO，作为一种固体、稳定的SO2等效物，实现了钯催化的芳基、烯基和杂芳基卤化物的氨基磺酰化反应。N,N-二烷基肼作为N-亲核试剂，在良好至优异的产率下提供了N-氨基磺酰胺产物。这些反应操作简单，仅需轻微过量的SO2（1.2-2.2 equiv.），并且能耐受卤化物偶联伙伴上的多种取代基。同时展示了肼组分的变化。使用N,N-二苄基肼作为N-亲核试剂得到的N-氨基磺酰胺产物，可以通过高产率的、连续的脱保护步骤转化为相应的伯磺酰胺。也展示了使用肼·SO2复合物作为N-亲核试剂和SO2来源的能力。
• Metathesis-active ligands enable a catalytic functional group metathesis between aroyl chlorides and aryl iodides
  作者：Yong Ho Lee、Bill Morandi

  DOI：10.1038/s41557-018-0078-8

  日期：2018.10

  for the most part, relied on relatively strong driving forces which often require highly reactive reagents to generate irreversibly a desired product in high yield and selectivity. These approaches generally prevent the use of the same catalytic strategy to perform the reverse reaction. Here we describe a catalytic functional group metathesis approach to interconvert, under CO-free conditions, two

  当前用于官能团互变的方法大部分依赖于相对强的驱动力，该驱动力通常需要高反应性的试剂以高收率和选择性不可逆地产生所需产物。这些方法通常阻止使用相同的催化策略进行逆反应。在这里，我们描述了一种催化官能团复分解方法，可在无CO条件下相互转化两类重要的亲电试剂，通常用于制备药物和农用化学品：芳酰氯（ArCOCl）和芳基碘化物（ArI）。我们的反应设计依赖于关键的可逆配体C–P键裂解事件的实施，这可以实现非清白的，复分解活性膦配体介导两个不同亲电试剂之间快速的芳基转移。除了为ArCOCl和ArI的相互转化提供一种实用且更安全的方法外，这种类型的配体非无毒性为开发使用合成相关的芳基亲电试剂的各种官能团复分解反应提供了一个蓝图。